A detailed history of Mink Brook Asset Management LLC transactions in Exagen Inc. stock. As of the latest transaction made, Mink Brook Asset Management LLC holds 130,000 shares of XGN stock, worth $1.52 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
130,000
Holding current value
$1.52 Million
% of portfolio
0.79%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$3.93 - $7.71 $510,900 - $1 Million
130,000 New
130,000 $907 Million

Others Institutions Holding XGN

About EXAGEN INC.


  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $191M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Mink Brook Asset Management LLC Portfolio

Follow Mink Brook Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mink Brook Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mink Brook Asset Management LLC with notifications on news.